These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24339137)

  • 1. Sequence analysis of 17 NRXN1 deletions.
    Enggaard Hoeffding LK; Hansen T; Ingason A; Doung L; Thygesen JH; Møller RS; Tommerup N; Kirov G; Rujescu D; Larsen LA; Werge T
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):52-61. PubMed ID: 24339137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs.
    Chen X; Shen Y; Zhang F; Chiang C; Pillalamarri V; Blumenthal I; Talkowski M; Wu BL; Gusella JF
    Am J Hum Genet; 2013 Mar; 92(3):375-86. PubMed ID: 23472757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of NRXN1 deletions: clinical and molecular characterization.
    Dabell MP; Rosenfeld JA; Bader P; Escobar LF; El-Khechen D; Vallee SE; Dinulos MB; Curry C; Fisher J; Tervo R; Hannibal MC; Siefkas K; Wyatt PR; Hughes L; Smith R; Ellingwood S; Lacassie Y; Stroud T; Farrell SA; Sanchez-Lara PA; Randolph LM; Niyazov D; Stevens CA; Schoonveld C; Skidmore D; MacKay S; Miles JH; Moodley M; Huillet A; Neill NJ; Ellison JW; Ballif BC; Shaffer LG
    Am J Med Genet A; 2013 Apr; 161A(4):717-31. PubMed ID: 23495017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions.
    Schaaf CP; Boone PM; Sampath S; Williams C; Bader PI; Mueller JM; Shchelochkov OA; Brown CW; Crawford HP; Phalen JA; Tartaglia NR; Evans P; Campbell WM; Tsai AC; Parsley L; Grayson SW; Scheuerle A; Luzzi CD; Thomas SK; Eng PA; Kang SH; Patel A; Stankiewicz P; Cheung SW
    Eur J Hum Genet; 2012 Dec; 20(12):1240-7. PubMed ID: 22617343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature.
    Béna F; Bruno DL; Eriksson M; van Ravenswaaij-Arts C; Stark Z; Dijkhuizen T; Gerkes E; Gimelli S; Ganesamoorthy D; Thuresson AC; Labalme A; Till M; Bilan F; Pasquier L; Kitzis A; Dubourgm C; Rossi M; Bottani A; Gagnebin M; Sanlaville D; Gilbert-Dussardier B; Guipponi M; van Haeringen A; Kriek M; Ruivenkamp C; Antonarakis SE; Anderlid BM; Slater HR; Schoumans J
    Am J Med Genet B Neuropsychiatr Genet; 2013 Jun; 162B(4):388-403. PubMed ID: 23533028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1.
    Nag A; Bochukova EG; Kremeyer B; Campbell DD; Muller H; Valencia-Duarte AV; Cardona J; Rivas IC; Mesa SC; Cuartas M; Garcia J; Bedoya G; Cornejo W; Herrera LD; Romero R; Fournier E; Reus VI; Lowe TL; Farooqi IS; ; Mathews CA; McGrath LM; Yu D; Cook E; Wang K; Scharf JM; Pauls DL; Freimer NB; Plagnol V; Ruiz-Linares A
    PLoS One; 2013; 8(3):e59061. PubMed ID: 23533600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.
    Lowther C; Speevak M; Armour CM; Goh ES; Graham GE; Li C; Zeesman S; Nowaczyk MJ; Schultz LA; Morra A; Nicolson R; Bikangaga P; Samdup D; Zaazou M; Boyd K; Jung JH; Siu V; Rajguru M; Goobie S; Tarnopolsky MA; Prasad C; Dick PT; Hussain AS; Walinga M; Reijenga RG; Gazzellone M; Lionel AC; Marshall CR; Scherer SW; Stavropoulos DJ; McCready E; Bassett AS
    Genet Med; 2017 Jan; 19(1):53-61. PubMed ID: 27195815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
    Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the neurexin 1 gene is associated with schizophrenia.
    Rujescu D; Ingason A; Cichon S; Pietiläinen OP; Barnes MR; Toulopoulou T; Picchioni M; Vassos E; Ettinger U; Bramon E; Murray R; Ruggeri M; Tosato S; Bonetto C; Steinberg S; Sigurdsson E; Sigmundsson T; Petursson H; Gylfason A; Olason PI; Hardarsson G; Jonsdottir GA; Gustafsson O; Fossdal R; Giegling I; Möller HJ; Hartmann AM; Hoffmann P; Crombie C; Fraser G; Walker N; Lonnqvist J; Suvisaari J; Tuulio-Henriksson A; Djurovic S; Melle I; Andreassen OA; Hansen T; Werge T; Kiemeney LA; Franke B; Veltman J; Buizer-Voskamp JE; ; Sabatti C; Ophoff RA; Rietschel M; Nöthen MM; Stefansson K; Peltonen L; St Clair D; Stefansson H; Collier DA
    Hum Mol Genet; 2009 Mar; 18(5):988-96. PubMed ID: 18945720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of NRXN1 gene deletion in an autistic patient].
    Zhou S; Song B; Liu N; Tan S; Yang Y; Zhang X; Luo H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Sep; 36(9):935-937. PubMed ID: 31515794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide Analysis of the Role of Copy Number Variation in Schizophrenia Risk in Chinese.
    Li Z; Chen J; Xu Y; Yi Q; Ji W; Wang P; Shen J; Song Z; Wang M; Yang P; Wang Q; Feng G; Liu B; Sun W; Xu Q; Li B; He L; He G; Li W; Wen Z; Liu K; Huang F; Zhou J; Ji J; Li X; Shi Y
    Biol Psychiatry; 2016 Aug; 80(4):331-337. PubMed ID: 26795442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.
    Lionel AC; Vaags AK; Sato D; Gazzellone MJ; Mitchell EB; Chen HY; Costain G; Walker S; Egger G; Thiruvahindrapuram B; Merico D; Prasad A; Anagnostou E; Fombonne E; Zwaigenbaum L; Roberts W; Szatmari P; Fernandez BA; Georgieva L; Brzustowicz LM; Roetzer K; Kaschnitz W; Vincent JB; Windpassinger C; Marshall CR; Trifiletti RR; Kirmani S; Kirov G; Petek E; Hodge JC; Bassett AS; Scherer SW
    Hum Mol Genet; 2013 May; 22(10):2055-66. PubMed ID: 23393157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the NRXN1 gene in a Chinese autism cohort.
    Liu Y; Hu Z; Xun G; Peng Y; Lu L; Xu X; Xiong Z; Xia L; Liu D; Li W; Zhao J; Xia K
    J Psychiatr Res; 2012 May; 46(5):630-4. PubMed ID: 22405623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete penetrance of NRXN1 deletions in families with schizophrenia.
    Todarello G; Feng N; Kolachana BS; Li C; Vakkalanka R; Bertolino A; Weinberger DR; Straub RE
    Schizophr Res; 2014 May; 155(1-3):1-7. PubMed ID: 24680031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes.
    Mozhui K; Wang X; Chen J; Mulligan MK; Li Z; Ingles J; Chen X; Lu L; Williams RW
    Transl Psychiatry; 2011 Jul; 1(7):e25. PubMed ID: 22832527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy.
    Møller RS; Weber YG; Klitten LL; Trucks H; Muhle H; Kunz WS; Mefford HC; Franke A; Kautza M; Wolf P; Dennig D; Schreiber S; Rückert IM; Wichmann HE; Ernst JP; Schurmann C; Grabe HJ; Tommerup N; Stephani U; Lerche H; Hjalgrim H; Helbig I; Sander T;
    Epilepsia; 2013 Feb; 54(2):256-64. PubMed ID: 23294455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
    Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C
    BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population.
    Yue W; Yang Y; Zhang Y; Lu T; Hu X; Wang L; Ruan Y; Lv L; Zhang D
    Behav Brain Funct; 2011 Apr; 7():7. PubMed ID: 21477380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review.
    Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM
    Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.